1. The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary.
- Author
-
Kandalaft PL, Gown AM, and Isacson C
- Subjects
- Adenocarcinoma, Clear Cell metabolism, Carcinoma, Endometrioid diagnosis, Diagnosis, Differential, Female, Humans, Ovarian Neoplasms metabolism, Retrospective Studies, Sensitivity and Specificity, Adenocarcinoma, Clear Cell diagnosis, Aspartic Acid Endopeptidases biosynthesis, Biomarkers, Tumor analysis, Ovarian Neoplasms diagnosis
- Abstract
Objectives: We recently observed expression of the "lung" marker napsin A in ovarian clear cell carcinomas and therefore sought to determine the extent of napsin A expression in a subset of ovarian neoplasms., Methods: We identified an archival series of ovarian clear cell carcinomas (n = 36), serous borderline tumors (n = 21), high-grade serous carcinomas (n = 37), and endometrioid adenocarcinomas (n = 29). Using standard immunohistochemical techniques on whole sections of formalin-fixed, paraffin-embedded specimens, we employed a panel of antibodies: napsin A (IP64), estrogen receptor (SP1), WT-1 (6F-H2), PAX-8 (BC12), and TTF-1 (SPT24)., Results: Thirty-six of 36 clear cell carcinomas showed napsin A expression, typically in a uniform pattern. None of the serous borderline tumors or high-grade serous carcinomas manifested napsin A expression. Napsin A was expressed in three (10%) of 29 endometrioid adenocarcinomas, generally in a focal pattern., Conclusions: Our study showed that napsin A is an extremely sensitive (100%) marker of ovarian clear cell carcinomas and exhibits very high specificity (100%) in distinguishing clear cell carcinomas from high-grade serous carcinomas and serous borderline tumors and 90% specificity in discriminating clear cell carcinomas from endometrioid carcinomas., (Copyright© by the American Society for Clinical Pathology.)
- Published
- 2014
- Full Text
- View/download PDF